Kyle Joseph
Achalasia is an uncommon illness characterized by a lack of lower
esophageal sphincter relaxation and esophageal peristalsis. Initial
treatment options include endoscopic balloon dilatation and
laparoscopic surgical myotomy. Esophagectomy's indications and
results in the therapy of end-stage achalasia are less well defined [1].
Because the origin of this illness is unknown, the goal of treatment
is to enhance esophageal emptying by removing the lower
esophageal sphincter's outflow resistance. Pneumatic dilatation
or surgical myotomy, which are the only long-term successful
treatments for achalasia, can help achieve this aim.
